CIK 0001372514 · Non-accelerated filer<br>Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980443284
- Phone
- 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-21 | Tosca Melissa EVP of Finance | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-10-21 | Strem Brian M. President and CEO | Grant or award | +12,500 | 13,183 | ||
| 2022-10-21 | Strem Brian M. President and CEO | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2022-02-10 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −108 | $0.69 | $75 | 22,746 |
| 2022-02-01 | Romano Sarah Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-02-01 | TYLE PRAVEEN Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-02-01 | CHANEY PAUL G Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-02-01 | Gayron Kenneth L Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-02-01 | Parsons Erin Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2022-02-01 | Parsons Erin Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-02-01 | Daniels Eric Joseph Chief Development Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-02-01 | Hollander David Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2022-02-01 | Hollander David Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-02-01 | Strem Brian M. President and CEO | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2022-02-01 | Shapiro Aron Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-01-05 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −114 | $1.08 | $123 | 22,854 |
| 2022-01-05 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −326 | $1.08 | $352 | 67,693 |
| 2021-12-07 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −273 | $1.30 | $355 | 68,019 |
| 2021-12-07 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −91 | $1.30 | $118 | 22,968 |
| 2021-11-18 | Strem Brian M. President and CEO | Purchase | +17,853 | $1.41 | $25K | 27,370 |
Page 5 of 7 · 130 trades